Quaker Chemical stock jumped 3.6% to US$160.52 into the close, and the move lines up with the story in the earnings. The market is latching onto one thing above all else: this quarter was about profit power. Adjusted EBITDA hit a record US$85m with margin at 16%, and non GAAP earnings per share came in at US$2.19. For a specialty chemicals supplier that lives or dies on mix and efficiency, that margin performance is what is driving today’s relief in the share price.
Is Quaker Chemical now a genuine bargain after record margins, or is the discount simply the market pricing in its risks? Compare the current US$160.52 share price against the detailed valuation analysis for Quaker Chemical
Prefer clean visuals over another long earnings recap? View Quaker Chemical’s full financial picture in an easy-to-read dashboard, with revenue, earnings and margins set out in clear charts in the company report for Quaker Chemical.
Bulls argue Quaker Houghton can turn specialty chemistries, digital services and Asia exposure into structurally higher profitability. Q2 gives that claim more substance. Volumes rose 7% on what management calls broad share gains, and Asia Pacific delivered a second quarter of double digit organic growth, helped by the new Zhangjiagang plant and local for local manufacturing. That fits the thesis of deeper regional roots. Adjusted EBITDA reached a record US$85m with margin at 16%, up 0.4 percentage points year on year and 0.9 points sequentially, while non GAAP EPS reached US$2.19 and has grown for four straight quarters. Transformation actions are already delivering roughly US$10m of annual run rate savings and management is still targeting gross margin above 36% and long term adjusted EBITDA margins above 18%. The bull story of mix plus self help is at least partially visible in the current numbers.
Bears focus on macro risk, execution and financial discipline. Q2 reduces some of that concern but does not clear it. Profitability returned, with net income of US$26.84m versus a loss in the prior year, and EMEA swung higher on price actions and manufacturing savings after the Dortmund closure. However, Americas segment earnings slipped about 3% despite 4% volume growth, held back by higher operating costs, a 24/7 plant and inventory builds. That supports the view that mix and complexity can still weigh on margins. Raw materials remain volatile and management expects only flat gross margin in Q3 before any improvement, so input cost risk is not fully behind Quaker Houghton. Operating cash flow fell to US$29m from US$42m as working capital absorbed more cash, even as the company lifted dividends and started a US$250m buyback. The print shows progress, but also why bears still question the durability of the margin story.
Reveal where the apparent calm around Quaker Chemical's current share price might hide a sharper turn in the next few years, and see where the consensus models start to break. Access the full revenue, earnings and free cash flow analyst estimates for Quaker Chemical.If Quaker Chemical’s record adjusted EBITDA and margin profile has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for your preferred entry point. Once you are invested, use the Portfolio Command Center to keep your holdings organised and focus only on the most important developments that matter to your thesis. For a longer term view, tap into the collective insight of other investors through the Community and see how sentiment and expectations evolve over time. By spotting potential catalysts and risks early, you give yourself a better chance to act with confidence and stay ahead of the market.
Fresh ideas are already building momentum while many investors stay focused on yesterday’s winners. Check these curated stock sets before the next breakout gets fully priced in and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com